The timing of early therapeutic strategies has a significant impact on Crohn's disease prognosis.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Digestive and Liver Disease

• Publication date

  2018-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.dld.2018.01.135PMID 29456097
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Impact of Early Surgery and Immunosuppression on Crohn's Disease Disabling Outcomes

  2017cited by this paper
• The risk of disabling, surgery and reoperation in Crohn’s disease – A decision tree-based approach to prognosis

  2017cited by this paper
• Development and Validation of Risk Matrices for Crohn’s Disease Outcomes in Patients Who Underwent Early Therapeutic Interventions

  2016cited by this paper
• Prevention of post-operative recurrence of Crohn's disease.

  2014cited by this paper
• Clinical prognostic factors for disabling Crohn's disease: a systematic review and meta-analysis.

  2013cited by this paper
• Prevention of Postoperative Recurrence of Crohn’s Disease: What Does the Evidence Support?

  2013cited by this paper
• Ustekinumab induction and maintenance therapy in refractory Crohn's disease.

  2012cited by this paper
• Epidemiology and natural history of inflammatory bowel diseases.

  2011cited by this paper
• Risk factors that predict the requirement of aggressive therapy among Chinese patients with Crohn's disease

  2011cited by this paper
• The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.

  2010cited by this paper
• The Natural History of Adult Crohn's Disease in Population-Based Cohorts

  2010cited by this paper
• Evolving inflammatory bowel disease treatment paradigms: top-down versus step-up.

  2010cited by this paper
• Predictors of severe Crohn's disease

  2008cited by this paper
• The effect of smoking after surgery for Crohn’s disease: a meta-analysis of observational studies

  2008cited by this paper
• Treatment of active Crohn's disease with MLN0002, a humanized antibody to the alpha4beta7 integrin.

  2008cited by this paper
• Inflammatory bowel disease: clinical aspects and established and evolving therapies

  2007cited by this paper
• Predictors of Crohn's disease.

  2006cited by this paper
• Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.

  2005cited by this paper
• Guidelines for the management of inflammatory bowel disease in adults

  2004cited by this paper
• Long-Term Evolution of Disease Behavior of Crohn's Disease

  2002cited by this paper
• Recurrence After Abdominal Surgery for Crohn’s Disease

  2002cited by this paper
• Risk factors for surgery and recurrence in 907 patients with primary ileocaecal Crohn's disease

  2000cited by this paper
• Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms.

  1992cited by this paper
• Recurrence after surgery in Crohn's disease. Relationship to location of disease (clinical pattern) and surgical indication.

  1985cited by this paper

• EARLY ILEOCECAL RESECTION IN CROHN’S DISEASE: A SYSTEMATIC REVIEW

  2026cites this paper
• Indicators for early surgery in patients with intra-abdominal fistulizing Crohn's disease

  2025cites this paper
• Composite outcomes in observational studies of Crohn’s disease: a systematic review and meta-analysis

  2022cites this paper
• Surgery for Crohn’s disease: upfront or last resort?

  2022cites this paper
• Ileal Crohn's Disease Exhibits Similar Transmural Fibrosis Irrespective of Phenotype

  2021cites this paper
• Pre-operative optimisation in Crohn's Disease

  2020cites this paper
• Inflammatory Bowel Disease - non-biological treatment.

  2020cites this paper
• Enfermedad inflamatoria intestinal preclínica: características de la enfermedad, pronóstico y necesidades de tratamiento

  2019cites this paper